Share-based Compensation (Tables)

9 Months Ended

Mar. 31, 2017

Share-based Compensation

Schedule of weighted average assumptions used to estimate fair values of the stock options granted and the estimated annual forfeiture rates used to recognize the associated compensation expense and the weighted average fair value of the options granted

	Nine Months Ended
	March 31, 2017			March 31, 2016
Risk-free interest rate	1.1		%	1.7		%
Expected volatility	55.6		%	48.3		%
Expected dividend yield	0.0		%	0.0		%
Forfeiture rate	6.5		%	6.5		%
Expected term (in years)	5.2 years			5.2 years
Weighted average fair value	$	15.33		$	26.24

Summary of stock option award activity

(In thousands, except for weighted average price and life data)	Awards		Weighted- Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Life (yrs.)
Outstanding at June 30, 2016	1,730		$	16.77	$	19,524	6.3
Granted	11		$	31.30
Exercised	(211	)	$	6.87	$	4,568
Forfeited, expired or repurchased	(25	)	$	32.89
Outstanding at March 31, 2017	1,505		$	17.99	$	14,431	5.9
Vested and expected to vest at March 31, 2017	1,500		$	17.91	$	14,431	5.9
Exercisable at March 31, 2017	1,355		$	15.68	$	14,431	5.8

Summary of nonvested restricted stock awards

(In thousands)	Awards		Weighted Average Grant - date Fair Value		Aggregate Intrinsic Value
Non-vested at June 30, 2016	167		$	48.22
Granted	290		$	24.86
Vested	(80	)	$	43.52	$	2,416
Forfeited	(35	)	$	34.10
Non-vested at March 31, 2017	342		$	30.89

Schedule of allocation of share-based compensation costs recognized in the Consolidated Statements of Operations by financial statement line item

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
(In thousands)	2017		2016		2017		2016
Selling, general and administrative expenses	$	1,345	$	1,511	$	4,568	$	6,891
Research and development expenses	175		195		500		584
Cost of sales	269		319		894		948
Total	$	1,789	$	2,025	$	5,962	$	8,423
Tax benefit at statutory rate	$	653	$	739	$	2,176	$	3,074